For example, robust testing for epidermal growth factor receptor (EGFR) gene mutational status in non small cell lung cancer (NSCLC) patients has defined this gene as an important predictive and prognostic factor in NSCLC diagnosis and treatment. Here, EGFR is linked to non-small cell lung carcinoma.